drugset / Trial / NCT02704481

Non-surgical Alternatives to Treatment of Failed Medical Abortion

NCT02704481

Phase 4 Terminated 16 enrolled Gynuity Health Projects
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.

Timeline

Start
2016-06-01
Primary completion
2019-01-16
Completion
2019-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 mg Oral
Subject Misoprostol Other / unclassified 800 ug Other

Indications

No indication recorded.